News First new Parkinson's treatment in decade gains US approval Newron's Xadago, a new add-on treatment for patients with Parkinson's disease, has been approved by the FDA.
News Outrage at Marathon's 'new drug' price, calls for PhRMA to a... Marathon under fire after US price hike.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
